Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 470

1.

Response versus remission in obsessive-compulsive disorder.

Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR.

J Clin Psychiatry. 2006 Feb;67(2):269-76.

PMID:
16566623
[PubMed - indexed for MEDLINE]
2.

Standard criteria for relapse are needed in obsessive-compulsive disorder.

Simpson HB, Franklin ME, Cheng J, Foa EB, Liebowitz MR.

Depress Anxiety. 2005;21(1):1-8.

PMID:
15806597
[PubMed - indexed for MEDLINE]
3.

Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder.

Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R.

Depress Anxiety. 2004;19(4):225-33.

PMID:
15274171
[PubMed - indexed for MEDLINE]
4.

Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.

Am J Psychiatry. 2005 Jan;162(1):151-61.

PMID:
15625214
[PubMed - indexed for MEDLINE]
5.

Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.

Tolin DF, Abramowitz JS, Diefenbach GJ.

J Clin Psychiatry. 2005 Dec;66(12):1549-57.

PMID:
16401156
[PubMed - indexed for MEDLINE]
6.

Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.

Hembree EA, Riggs DS, Kozak MJ, Franklin ME, Foa EB.

CNS Spectr. 2003 May;8(5):363-71, 381.

PMID:
12766692
[PubMed - indexed for MEDLINE]
7.

Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.

Albert U, Aguglia E, Maina G, Bogetto F.

J Clin Psychiatry. 2002 Nov;63(11):1004-9.

PMID:
12444814
[PubMed - indexed for MEDLINE]
8.

Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.

Simpson HB, Gorfinkle KS, Liebowitz MR.

J Clin Psychiatry. 1999 Sep;60(9):584-90.

PMID:
10520976
[PubMed - indexed for MEDLINE]
9.

Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

Tenneij NH, van Megen HJ, Denys DA, Westenberg HG.

J Clin Psychiatry. 2005 Sep;66(9):1169-75.

PMID:
16187776
[PubMed - indexed for MEDLINE]
10.

Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.

DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.

Psychopharmacol Bull. 1990;26(1):54-9.

PMID:
2196627
[PubMed - indexed for MEDLINE]
11.

Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.

Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, Tarlow G, Bystritsky A.

J Clin Psychiatry. 2002 Jan;63(1):21-7.

PMID:
11838621
[PubMed - indexed for MEDLINE]
12.

A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.

Saxena S, Winograd A, Dunkin JJ, Maidment K, Rosen R, Vapnik T, Tarlow G, Bystritsky A.

J Clin Psychiatry. 2001 Jan;62(1):67-72; quiz 73.

PMID:
11235937
[PubMed - indexed for MEDLINE]
13.

Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.

Simpson HB, Petkova E, Cheng J, Huppert J, Foa E, Liebowitz MR.

J Psychiatr Res. 2008 Jul;42(8):631-8. Epub 2007 Sep 24.

PMID:
17892885
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.

Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV.

J Clin Psychiatry. 2006 Jul;67(7):1133-9.

PMID:
16889458
[PubMed - indexed for MEDLINE]
15.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
[PubMed - indexed for MEDLINE]
16.

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J Jr, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R.

JAMA Psychiatry. 2013 Nov;70(11):1190-9. doi: 10.1001/jamapsychiatry.2013.1932.

PMID:
24026523
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, Vallejo J.

J Clin Psychiatry. 2001 Jul;62(7):535-40.

PMID:
11488364
[PubMed - indexed for MEDLINE]
18.

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.

J Clin Psychiatry. 2005 Apr;66(4):515-20.

PMID:
15816795
[PubMed - indexed for MEDLINE]
19.

Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

van Oppen P, van Balkom AJ, de Haan E, van Dyck R.

J Clin Psychiatry. 2005 Nov;66(11):1415-22.

PMID:
16420079
[PubMed - indexed for MEDLINE]
20.

Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.

Pallanti S, Quercioli L, Bruscoli M.

J Clin Psychiatry. 2004 Oct;65(10):1394-9.

PMID:
15491244
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk